Published in Transplantation on April 01, 1980
Isolation and partial nucleotide sequence of a cDNA clone for human histocompatibility antigen HLA-B by use of an oligodeoxynucleotide primer. Proc Natl Acad Sci U S A (1981) 6.03
Regulation of CNS synapses by neuronal MHC class I. Proc Natl Acad Sci U S A (2007) 2.25
Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer. J Clin Pathol (1981) 1.87
Antigen presentation in brain: MHC induction on brain endothelium and astrocytes compared. Immunology (1987) 1.24
Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody. Gut (1981) 1.23
Developmental and tissue-specific expression of nuclear proteins that bind the regulatory element of the major histocompatibility complex class I gene. J Exp Med (1989) 1.22
Adenovirus E1A-mediated regulation of class I MHC expression. EMBO J (1986) 1.16
Expression of HLA class I antigens on hepatocytes in liver disease. Am J Pathol (1986) 1.10
Weak HLA and beta 2-microglobulin expression of neuronal cell lines can be modulated by interferon. Proc Natl Acad Sci U S A (1984) 1.01
Graft-vs.-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system. Proc Natl Acad Sci U S A (1987) 0.95
Inducibility of Ia antigen on astrocytes by murine coronavirus JHM is rat strain dependent. J Exp Med (1987) 0.94
Paralysis of street rabies virus-infected mice is dependent on T lymphocytes. J Virol (1992) 0.91
Mononuclear cells in acute allograft glomerulopathy. Am J Pathol (1987) 0.89
Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro. Proc Natl Acad Sci U S A (1986) 0.88
Inhibition of HLA class I antigen and mRNA expression induced by Rous sarcoma virus in transformed human fibroblasts. Proc Natl Acad Sci U S A (1988) 0.88
The distribution of a specific HLA-B27-associated cell surface component on the tissues of patients with ankylosing spondylitis. Clin Exp Immunol (1981) 0.85
Susceptibility to Theiler's virus-induced demyelinating disease correlates with astrocyte class II induction and antigen presentation. Immunology (1992) 0.84
Selective acceptance of MHC class I-deficient tumor grafts in the brain. J Exp Med (1988) 0.82
Specific suppression of major histocompatibility complex class I and class II genes in astrocytes by brain-enriched gangliosides. J Exp Med (1993) 0.81
Heterogeneity of HLA-DR+ cells in normal human kidney. Immunohistological and cytochemical characterisation of discrete cell populations. J Clin Pathol (1983) 0.78
T cell responses in the central nervous system. Nat Rev Immunol (2017) 0.76
Transcriptional regulation of MHC class I gene expression in rat oligodendrocytes. Biochem J (1998) 0.75
Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation. Transpl Infect Dis (2015) 0.75
Linguistic experience alters phonetic perception in infants by 6 months of age. Science (1992) 6.71
Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens (1995) 6.33
A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. Eur J Immunol (1979) 5.17
Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain. J Exp Med (1981) 5.00
Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med (1990) 4.48
Legionnaires' disease in a transplant unit: isolation of the causative agent from shower baths. Lancet (1980) 4.04
Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med (1990) 3.73
"Hyperacute" renal-homograft rejection in man. N Engl J Med (1968) 3.37
Organisation of vascular surgical services: evolution or revolution? BMJ (1994) 3.28
IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol (2001) 3.22
Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol (1998) 3.19
Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med (1995) 3.16
Monoclonal antibody to a human leukocyte-specific membrane glycoprotein probably homologous to the leukocyte-common (L-C) antigen of the rat. Eur J Immunol (1980) 3.10
Unrecognized human immunodeficiency virus infection in emergency department patients. N Engl J Med (1988) 3.08
Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone. J Exp Med (1988) 2.98
Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues. J Exp Med (1988) 2.73
Non-random distribution of amino acids in the transmembrane segments of human type I single span membrane proteins. J Mol Biol (1993) 2.70
Association of autoimmune active chronic hepatitis with HL-A1,8. Lancet (1972) 2.69
Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect (1981) 2.52
Urological complications in 1,000 consecutive renal transplant recipients. J Urol (1995) 2.48
The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation (1984) 2.45
The survival of patients with colorectal cancer treated in a regional hospital. Br J Surg (1978) 2.27
The detailed distribution of MHC Class II antigens in normal human organs. Transplantation (1984) 2.26
Systemic cytokine response after major surgery. Br J Surg (1992) 2.23
Studies on the immunosuppressive properties of cyclosporin a in rats receiving renal allografts. Transplantation (1980) 2.21
Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis. Am J Transplant (2012) 2.18
Surgical management of the thoracic outlet compression syndrome. Br J Surg (1991) 2.13
Interactive effect of Gm allotypes and HLA-B locus antigens on the human antibody response to a bacterial antigen. Clin Exp Immunol (1980) 2.12
The Northwick Park Neck Pain Questionnaire, devised to measure neck pain and disability. Br J Rheumatol (1994) 2.11
Quantitative serological analysis of a rabbit anti-rat lymphocyte serum and preliminary biochemical characterisation of the major antigen recognised. Transplantation (1977) 2.01
Identification and unusual tissue distribution of the canine and human homologues of Thy-1 (theta). J Exp Med (1979) 2.00
Mitotic activity of corneal endothelial cells in organ culture with recombinant human epidermal growth factor. Ophthalmology (1987) 1.96
Influence of trauma on the development of chronic inflammatory polyarthritis. Ann Rheum Dis (1967) 1.93
Carotid endarterectomy in Great Britain and Ireland. Br J Surg (1986) 1.90
Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type. Diabetes (1977) 1.88
Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation (1986) 1.88
The gene, MIC4, which controls expression of the antigen defined by monoclonal antibody F10.44.2, is on human chromosome 11. Eur J Immunol (1982) 1.86
A mixed culture recovery method indicates that enteric bacteria do not enter the viable but nonculturable state. Appl Environ Microbiol (1998) 1.85
Monoclonal antibody to a human brain-granulocyte-T lymphocyte antigen probably homologous to the W 3/13 antigen of the rat. Eur J Immunol (1980) 1.84
Pancreaticoduodenal cancer. Experience from 1951 to 1960 with a look ahead and behind. Arch Surg (1966) 1.83
Human thy-1: unusual localization and possible functional significance in lymphoid tissues. J Immunol (1981) 1.79
Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10. Transplantation (2001) 1.74
Cyclosporin A. Transplantation (1981) 1.72
Alpha-helical, but not beta-sheet, propensity of proline is determined by peptide environment. Proc Natl Acad Sci U S A (1996) 1.67
Provision of vascular surgical services in the Oxford Region. Br J Surg (1994) 1.65
Recovery of hydrogen peroxide-sensitive culturable cells of Vibrio vulnificus gives the appearance of resuscitation from a viable but nonculturable state. J Bacteriol (2000) 1.63
Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med (1991) 1.62
A method for isolation of islets of Langerhans from the human pancreas. Diabetes (1984) 1.60
Mortality in gold and coal miners in Western Australia with special reference to lung cancer. Br J Ind Med (1979) 1.59
Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Evidence of a clear role for short-term antigen persistence. Transplantation (1995) 1.58
myo-inositol pentakisphosphates. Structure, biological occurrence and phosphorylation to myo-inositol hexakisphosphate. Biochem J (1991) 1.57
Massive induction of donor-type class I and class II major histocompatibility complex antigens in rejecting cardiac allografts in the rat. J Exp Med (1985) 1.57
Major histocompatibility complex antigens in rat kidney, ureter, and bladder. Localization with monoclonal antibodies and demonstration of Ia-positive dendritic cells. Transplantation (1981) 1.55
Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet (1996) 1.54
Long-term follow-up after weight management in obese dogs: the role of diet in preventing regain. Vet J (2011) 1.53
Genetic susceptibility to the development of retinopathy in insulin-dependent diabetics. Diabetes (1982) 1.53
The effect of smoking on the late patency of arterial reconstructions in the legs. Br J Surg (1978) 1.51
Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. Eur J Vasc Endovasc Surg (1996) 1.51
Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation (2004) 1.51
The mortality of abdominal aortic aneurysm. Ann R Coll Surg Engl (1986) 1.50
Phenotypic characterization of five dendritic cell subsets in human tonsils. Am J Pathol (2001) 1.49
T cell activation by anti-T3 antibodies: comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors. Eur J Immunol (1986) 1.49
The urological complications of renal transplantation: a series of 1535 patients. BJU Int (2002) 1.48
Upper gastrointestinal haemorrhage in Oxford. A prospective study. J R Coll Surg Edinb (1984) 1.48
Infective agents and embryopathy in the west of Scotland 1966-1970. Scott Med J (1972) 1.48
Treatment of postoperative otorrhoea by grafting of mastoid cavities with cultured autologous epidermal cells. Lancet (1990) 1.47
Death of the Escherichia coli K-12 strain W3110 in soil and water. Appl Environ Microbiol (1996) 1.46
Portal endotoxin and cytokine responses during abdominal aortic surgery. Am J Surg (1993) 1.45
An intelligent learning environment for advanced cardiac life support. Proc AMIA Annu Fall Symp (1996) 1.44
Anomolous expression of HLA-DR antigens on human colorectal cancer cells. J Immunol (1982) 1.44
Effector mechanisms in allograft rejection. Annu Rev Immunol (1986) 1.43
Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: a first step toward the gene therapy of chronic rejection. Transplantation (2000) 1.43
Hodgkin's cells express CD83, a dendritic cell lineage associated antigen. Pathology (1997) 1.43
Carotid duplex scanning: patterns of referral and outcome. Eur J Vasc Endovasc Surg (1995) 1.40
Identification of a cell surface protein complex mediating phorbol ester-induced adhesion (binding) among human mononuclear leukocytes. Scand J Immunol (1985) 1.40
Role of transplantation in the management of hepatic malignancy. Br J Surg (2007) 1.40
Isolation and characterization of dendritic cells from mouse heart and kidney. J Immunol (1994) 1.40
The effect of donor strain blood pretreatment on renal allograft rejection in rats. Transplantation (1972) 1.40
Tissue-binding properties of a synthetic peptide DNA vector targeted to cell membrane integrins: a possible universal nonviral vector for organ and tissue transplantation. Transplantation (2000) 1.40
Auditing the vascular surgical audit. Br J Surg (1987) 1.39
Training in fiberoptic intubation. Anaesthesia (2000) 1.38
Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". Eur J Vasc Endovasc Surg (2011) 1.38
Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients. Transplantation (1994) 1.37
The Ina and Inb blood group antigens are located on a glycoprotein of 80,000 MW (the CDw44 glycoprotein) whose expression is influenced by the In(Lu) gene. Immunology (1988) 1.37
Localization of major histocompatibility complex (HLA-ABC and DR) antigens in 46 kidneys. Differences in HLA-DR staining of tubules among kidneys. Transplantation (1983) 1.32
Carotid endarterectomy in Great Britain and Ireland: practice between 1984 and 1992. Br J Surg (1994) 1.31
A technique for lymphocyte preparation from stored heparinized blood. Vox Sang (1971) 1.31
Developments in isolated pancreatic islet transplantation. Transplantation (1987) 1.30
Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res (1998) 1.29
Wound dehiscence. A continuing problem in abdominal surgery. Arch Surg (1966) 1.29
Matching for HLA in transplantation. Br Med Bull (1978) 1.27